about
My approach to the treatment of sclerodermaAssociation of gender with clinical expression, quality of life, disability, and depression and anxiety in patients with systemic sclerosis.Psychological distress, personality traits and functional disability in patients with osteonecrosis of the femoral head.Sexual dysfunction in married women with Systemic SclerosisClinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey.Psychiatric symptoms and quality of life in systemic sclerosis.Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group StudyFatigue: an overlooked determinant of physical function in scleroderma.In systemic sclerosis, anxiety and depression assessed by hospital anxiety depression scale are independently associated with disability and psychological factors.(Not) talking about sex: a systematic comparison of sexual impairment in women with systemic sclerosis and other chronic disease samples.Improving Major Depressive Episode Assessment: A New Tool Developed by Formal Psychological Assessment.Negative affect in systemic sclerosis.Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis.Depression among the Moroccan systemic sclerosis.Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.A longitudinal analysis of humor coping and quality of life in systemic sclerosis.Correlation of articular involvement, skin disfigurement and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample.Mental health in patients with systemic sclerosis: a controlled investigation.Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms.Cutaneous concerns of scleroderma patients.
P2860
Q24618843-03588DD2-B80F-4F51-9397-5B24EF51F2FBQ33847277-57564DA7-9D2D-4EFE-AC77-96BD1EF1FC1EQ34016290-1CC74D78-7483-4489-9660-727B7B2B0200Q34587257-050EA1C9-5FBD-4042-A859-BD5A1F5F8793Q35109082-568E9894-0013-4619-BA9D-38005AFFD981Q35920153-7C7B1266-4851-4904-9D6E-EF89AC832084Q35967757-19E983CA-DCC0-4625-8519-90792289FEC7Q37089576-AF7D0F7C-73ED-4D4B-8720-76514D2019F5Q37101227-D389D2EC-0D4F-4ECC-85EB-86BEFFC6B114Q37347652-964092BD-6807-4156-98DC-D794A16D4879Q37647635-F3188D5F-0CE7-4B65-8996-0CEC33306170Q38144762-207480BB-3707-4B93-8FAB-A1F485B70616Q38609518-9C5CF46F-5B79-48DF-9AB7-AAA775772143Q39567416-6D729C4B-40D8-4BFC-A5F7-A9C7FF4B31DCQ39632069-F465318E-D1F4-459F-AC3A-FD430A1B9E15Q41701251-F2F5710D-E8C8-4346-9708-5A11CEBEA9C6Q44755169-6BC61A41-E550-4EE6-864E-CD8738320CA1Q48344320-11F6FC80-19FD-4B7B-A95A-714116B462BDQ50804361-6ED87E84-C441-446F-BB3A-6D011481BA3AQ51938404-BCA1BCF8-08F4-48FC-85AE-D61D8C964FE8Q53383961-DABB3305-05E5-4DB4-91BF-DEF68E536CF1
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Depressive symptoms associated with scleroderma.
@en
Depressive symptoms associated with scleroderma.
@nl
type
label
Depressive symptoms associated with scleroderma.
@en
Depressive symptoms associated with scleroderma.
@nl
prefLabel
Depressive symptoms associated with scleroderma.
@en
Depressive symptoms associated with scleroderma.
@nl
P2093
P2860
P356
P1476
Depressive symptoms associated with scleroderma.
@en
P2093
P2860
P304
P356
10.1002/ART.1780390623
P577
1996-06-01T00:00:00Z